Bank of America’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.98K | Sell |
8,910
-2,383
| -21% | -$2.67K | ﹤0.01% | 6168 |
|
|
2025
Q1 | $13K | Sell |
11,293
-8,700
| -44% | -$10K | ﹤0.01% | 6029 |
|
|
2024
Q4 | $122K | Buy |
19,993
+2,806
| +16% | +$17.1K | ﹤0.01% | 5438 |
|
|
2024
Q3 | $284K | Sell |
17,187
-7,132
| -29% | -$118K | ﹤0.01% | 4992 |
|
|
2024
Q2 | $167K | Buy |
24,319
+2,047
| +9% | +$14.1K | ﹤0.01% | 5174 |
|
|
2024
Q1 | $215K | Sell |
22,272
-2,460
| -10% | -$23.7K | ﹤0.01% | 5018 |
|
|
2023
Q4 | $206K | Buy |
24,732
+9,252
| +60% | +$76.9K | ﹤0.01% | 5150 |
|
|
2023
Q3 | $129K | Sell |
15,480
-1,127
| -7% | -$9.41K | ﹤0.01% | 5258 |
|
|
2023
Q2 | $153K | Buy |
16,607
+1,079
| +7% | +$9.96K | ﹤0.01% | 5168 |
|
|
2023
Q1 | $213K | Sell |
15,528
-2,446
| -14% | -$33.6K | ﹤0.01% | 5120 |
|
|
2022
Q4 | $306K | Buy |
17,974
+10,101
| +128% | +$172K | ﹤0.01% | 4969 |
|
|
2022
Q3 | $179K | Buy |
7,873
+923
| +13% | +$21K | ﹤0.01% | 5249 |
|
|
2022
Q2 | $125K | Buy |
6,950
+2,837
| +69% | +$51K | ﹤0.01% | 5589 |
|
|
2022
Q1 | $110K | Sell |
4,113
-11,922
| -74% | -$319K | ﹤0.01% | 6027 |
|
|
2021
Q4 | $470K | Buy |
16,035
+12,388
| +340% | +$363K | ﹤0.01% | 5158 |
|
|
2021
Q3 | $240K | Buy |
3,647
+626
| +21% | +$41.2K | ﹤0.01% | 5354 |
|
|
2021
Q2 | $251K | Sell |
3,021
-133
| -4% | -$11.1K | ﹤0.01% | 5181 |
|
|
2021
Q1 | $242K | Sell |
3,154
-1,194
| -27% | -$91.6K | ﹤0.01% | 5252 |
|
|
2020
Q4 | $384K | Buy |
4,348
+115
| +3% | +$10.2K | ﹤0.01% | 4486 |
|
|
2020
Q3 | $312K | Buy |
4,233
+377
| +10% | +$27.8K | ﹤0.01% | 4445 |
|
|
2020
Q2 | $282K | Buy |
3,856
+1,322
| +52% | +$96.7K | ﹤0.01% | 4488 |
|
|
2020
Q1 | $142K | Buy |
2,534
+1,756
| +226% | +$98.4K | ﹤0.01% | 4737 |
|
|
2019
Q4 | $29K | Buy |
+778
| New | +$29K | ﹤0.01% | 5586 |
|